Cargando…

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma

Human papillomavirus (HPV) is a major etiologic factor for oropharyngeal squamous cell carcinoma (OPSCC). However, little is known about HPV-related OPSCC in Japan. During the study, formalin-fixed, paraffin-embedded OPSCC specimens from Japanese patients were analyzed for HPV DNA by the polymerase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakami, Hisato, Okamoto, Isamu, Terao, Kyoichi, Sakai, Kazuko, Suzuki, Minoru, Ueda, Shinya, Tanaka, Kaoru, Kuwata, Kiyoko, Morita, Yume, Ono, Koji, Nishio, Kazuto, Nishimura, Yasumasa, Doi, Katsumi, Nakagawa, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892398/ https://www.ncbi.nlm.nih.gov/pubmed/24403267 http://dx.doi.org/10.1002/cam4.151

Ejemplares similares

MET amplification as a potential therapeutic target in gastric cancer
por: Kawakami, Hisato, et al.
Publicado: (2012)

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
por: Kawakami, Hisato, et al.
Publicado: (2014)

Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI
por: Yonesaka, Kimio, et al.
Publicado: (2019)

Targeting MET Amplification as a New Oncogenic Driver
por: Kawakami, Hisato, et al.
Publicado: (2014)

Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoter
por: SAKAI, KAZUKO, et al.
Publicado: (2015)

Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors
por: Uehara, Takuya, et al.
Publicado: (2021)

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts
por: Kato, Ryoji, et al.
Publicado: (2020)

Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010)

SRPX2 Is a Novel Chondroitin Sulfate Proteoglycan That Is Overexpressed in Gastrointestinal Cancer
por: Tanaka, Kaoru, et al.
Publicado: (2012)

A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood
por: Kawanaka, Yusuke, et al.
Publicado: (2020)

Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer
por: Watanabe, Satomi, et al.
Publicado: (2018)

Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis
por: Sakurai, Toshiharu, et al.
Publicado: (2021)

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples
por: Ishii, Hidenobu, et al.
Publicado: (2015)

Successful long-term treatment of non–small cell lung cancer positive for RET rearrangement with pemetrexed
por: Takeda, Masayuki, et al.
Publicado: (2019)

Oropharyngeal pleomorphic adenoma causing complete airway obstruction and cardiopulmonary arrest
por: Ono, Yuko, et al.
Publicado: (2022)

Modelling human papillomavirus biology in oropharyngeal keratinocytes
por: Roberts, Sally, et al.
Publicado: (2019)

Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
por: Sakai, Kazuko, et al.
Publicado: (2020)

Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib
por: Azuma, Koichi, et al.
Publicado: (2016)

The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer
por: Yonesaka, Kimio, et al.
Publicado: (2015)

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors
por: Yonesaka, Kimio, et al.
Publicado: (2019)

Human papillomavirus and oropharyngeal cancer in Greenland in 1994–2010
por: Avnstorp, Magnus Balslev, et al.
Publicado: (2013)

Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
por: Takeda, Masayuki, et al.
Publicado: (2018)

A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing
por: Sakai, Kazuko, et al.
Publicado: (2019)

Recent advances in managing human papillomavirus-positive oropharyngeal tumors
por: Cantu, Giulio, et al.
Publicado: (2010)

Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs
por: Isaac, Andre, et al.
Publicado: (2017)

Public awareness of the association between human papillomavirus and oropharyngeal cancer
por: Verhees, Femke, et al.
Publicado: (2021)

Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects
por: Oliva, Carolina, et al.
Publicado: (2022)

Clinical and immune profiling for cancer of unknown primary site
por: Haratani, Koji, et al.
Publicado: (2019)

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
por: Takegawa, Naoki, et al.
Publicado: (2015)

New Era for Next-Generation Sequencing in Japan
por: Takeda, Masayuki, et al.
Publicado: (2019)

Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC: A Case Report
por: Takakura, Toshiaki, et al.
Publicado: (2023)

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
por: Feller, Liviu, et al.
Publicado: (2010)

Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma
por: Baboci, Lorena, et al.
Publicado: (2013)

The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population
por: Lucas-Roxburgh, Rebecca, et al.
Publicado: (2017)

De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer
por: An, Yi, et al.
Publicado: (2016)

Educational Case: Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma
por: Shen, Minqian, et al.
Publicado: (2019)

An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
por: Zhong, Chengxue, et al.
Publicado: (2021)

Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers
por: Symer, David E., et al.
Publicado: (2022)

Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
por: Sano, Daisuke, et al.
Publicado: (2019)

Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
por: Hatano, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2tfts08iitme6ocrgmtlh0nt1t